标题
Advances in gene therapy for inborn errors of immunity
作者
关键词
-
出版物
Current Opinion in Allergy and Clinical Immunology
Volume 23, Issue 6, Pages 467-477
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-10-17
DOI
10.1097/aci.0000000000000952
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CRISPR technology: A decade of genome editing is only the beginning
- (2023) Joy Y. Wang et al. SCIENCE
- CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
- (2023) Julie Brault et al. Frontiers in Immunology
- Updated management guidelines for adenosine deaminase deficiency.
- (2023) Eyal Grunebaum et al. Journal of Allergy and Clinical Immunology-In Practice
- Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy
- (2023) Steicy Sobrino et al. Cell Reports Medicine
- Access to gene therapy for rare diseases when commercialization is not fit for purpose
- (2023) Thomas Fox et al. NATURE MEDICINE
- Gene Therapy for Inborn Errors of Immunity
- (2023) Tiphaine Arlabosse et al. Journal of Allergy and Clinical Immunology-In Practice
- Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT inborn errors working party analysis
- (2022) Michael H. Albert et al. BLOOD
- Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
- (2022) A. Magnani et al. NATURE MEDICINE
- A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders
- (2022) Francesca Tucci et al. Nature Communications
- Outcomes Following Treatment for Adenosine Deaminase Deficient Severe Combined Immunodeficiency: A Report from the PIDTC
- (2022) Geoffrey D.E. Cuvelier et al. BLOOD
- Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
- (2022) Stuart G. Tangye et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Ensuring a future for gene therapy for rare diseases
- (2022) Alessandro Aiuti et al. NATURE MEDICINE
- Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency
- (2022) Suk See De Ravin et al. Nature Communications
- Preclinical Safety and Efficacy of Lentiviral-Mediated Gene Therapy for Leukocyte Adhesion Deficiency Type I
- (2022) Cristina Mesa-Núñez et al. Molecular Therapy-Methods & Clinical Development
- Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT
- (2022) Catharina Schuetz et al. BLOOD
- Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
- (2022) Samuele Ferrari et al. Cell Stem Cell
- Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency
- (2022) Joseph Topal et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Therapeutic gene editing of T cells to correct CTLA-4 insufficiency
- (2022) Thomas Andrew Fox et al. Science Translational Medicine
- Lentiviral Gene Therapy with Low Dose Conditioning for X-Linked SCID Results in Complete Immune Reconstitution and No Evidence of Clonal Expansion
- (2022) Claire Booth et al. BLOOD
- Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
- (2022) Claire Booth et al. BLOOD
- Lentiviral Gene Therapy for Artemis-Deficient SCID
- (2022) Morton J. Cowan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome
- (2021) Valentina Vavassori et al. EMBO Molecular Medicine
- Effective, safe and sustained correction of murine XLA using a UCOE-BTK promoter based lentiviral vector
- (2021) Brenda J. Seymour et al. Molecular Therapy-Methods & Clinical Development
- Enhanced Homology-directed Repair for Highly Efficient Gene Editing in Hematopoietic Stem/Progenitor Cells
- (2021) Suk See De Ravin et al. BLOOD
- Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq
- (2021) Giandomenico Turchiano et al. Cell Stem Cell
- Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair
- (2021) Colin L. Sweeney et al. GENE THERAPY
- SCID newborn screening: What we’ve learned
- (2021) Robert Currier et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Gene Editing Rescues In vitro T Cell Development of RAG2-Deficient Induced Pluripotent Stem Cells in an Artificial Thymic Organoid System
- (2021) Cameron L. Gardner et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A Novel Branched DNA-Based Flowcytometric Method for Single-Cell Characterization of Gene Therapy Products and Expression of Therapeutic Genes
- (2021) Laura Garcia-Perez et al. Frontiers in Immunology
- Long-term Outcomes after Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (ADA SCID)
- (2021) Bryanna C. Reinhardt et al. BLOOD
- Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
- (2021) Donald B. Kohn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rescue of STAT3 Function in Hyper-IgE Syndrome Using Adenine Base Editing
- (2021) Andreas C. Eberherr et al. CRISPR Journal
- In vivo somatic cell base editing and prime editing
- (2021) Gregory A. Newby et al. MOLECULAR THERAPY
- Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning
- (2021) Adrian Schwarzer et al. MOLECULAR THERAPY
- Built to last: gene therapy for ADA SCID
- (2021) Sung-Yun Pai BLOOD
- Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort
- (2021) Arjan C. Lankester et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lentiviral gene therapy for X-linked chronic granulomatous disease
- (2020) Donald B. Kohn et al. NATURE MEDICINE
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Lentiviral gene therapy for familial hemophagocytic lymphohistiocytosis type 3, caused by UNC13D genetic defects
- (2020) Sarah Takushi et al. HUMAN GENE THERAPY
- Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and Adults
- (2020) Robert Chiesa et al. BLOOD
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function
- (2020) Yuchi Honaker et al. Science Translational Medicine
- Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
- (2020) Rajeev Rai et al. Nature Communications
- Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID
- (2020) Laura Garcia-Perez et al. Molecular Therapy-Methods & Clinical Development
- Adenosine Deaminase (ADA)–Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry
- (2020) Caroline Y. Kuo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Tools for experimental and computational analyses of off-target editing by programmable nucleases
- (2020) X. Robert Bao et al. Nature Protocols
- Gene therapy using haematopoietic stem and progenitor cells
- (2020) Giuliana Ferrari et al. NATURE REVIEWS GENETICS
- Outcome of chronic granulomatous disease ‐ Conventional treatment vs stem cell transplantation
- (2020) Cinzia Dedieu et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Ex Vivo Expansion of Hematopoietic Stem Cells for Therapeutic Purposes: Lessons from Development and the Niche
- (2019) Parisa Tajer et al. Cells
- Retroviral UNC13D Gene Transfer Restores Cytotoxic Activity of T Cells Derived from Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients In Vitro
- (2019) Viviane Dettmer et al. HUMAN GENE THERAPY
- Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
- (2019) Ewelina Mamcarz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
- (2019) Francesca Ferrua et al. Lancet Haematology
- Gene correction for SCID-X1 in long-term hematopoietic stem cells
- (2019) Mara Pavel-Dinu et al. Nature Communications
- Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency
- (2019) Andrew R. Gennery et al. Frontiers in Pediatrics
- Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives
- (2019) Frank J. T. Staal et al. Frontiers in Pediatrics
- HypomorphicRag1mutations alter the preimmune repertoire at early stages of lymphoid development
- (2018) L. M. Ott de Bruin et al. BLOOD
- Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): Not only infections, but high risk of autoimmune complications
- (2018) Domenico Umberto De Rose et al. CLINICAL IMMUNOLOGY
- T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations
- (2018) Sujal Ghosh et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease
- (2018) Neelam Panchal et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
- (2018) Caroline Y. Kuo et al. Cell Reports
- SCID genotype and 6-month post-transplant CD4 count predict survival and immune recovery: a PIDTC retrospective study
- (2018) Elie Haddad et al. BLOOD
- Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation
- (2017) Valentina Capo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations
- (2017) Kathryn L. Bradford et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome
- (2017) Fabio Candotti JOURNAL OF CLINICAL IMMUNOLOGY
- Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency
- (2017) Kit L. Shaw et al. JOURNAL OF CLINICAL INVESTIGATION
- CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
- (2017) Suk See De Ravin et al. Science Translational Medicine
- Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
- (2017) Giulia Schiroli et al. Science Translational Medicine
- Ectopic FOXP3 Expression Preserves Primitive Features Of Human Hematopoietic Stem Cells While Impairing Functional T Cell Differentiation
- (2017) F. R. Santoni de Sio et al. Scientific Reports
- From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation
- (2016) Rosa Bacchetta et al. Annals of the New York Academy of Sciences
- Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice
- (2016) T. Soheili et al. BLOOD
- Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome
- (2016) Nicholas Hubbard et al. BLOOD
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
- (2016) Maria Rosa Lidonnici et al. HAEMATOLOGICA
- The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy
- (2016) Maria Ester Bernardo et al. HUMAN GENE THERAPY
- A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome
- (2016) Zeynep Yesim Kucuk et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions
- (2016) Maren Weisser et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease
- (2016) Suk See De Ravin et al. NATURE BIOTECHNOLOGY
- Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
- (2016) Suk See De Ravin et al. Science Translational Medicine
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
- (2016) Maria Rosa Lidonnici et al. HAEMATOLOGICA
- DCLRE1C(ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency
- (2015) Timo Volk et al. HUMAN MOLECULAR GENETICS
- Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
- (2015) Salima Hacein-Bey Abina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency
- (2015) Kerstin Felgentreff et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Perforin Gene Transfer Into Hematopoietic Stem Cells Improves Immune Dysregulation in Murine Models of Perforin Deficiency
- (2015) Marlene Carmo et al. MOLECULAR THERAPY
- Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies
- (2015) Lisa M. Ott de Bruin et al. Frontiers in Immunology
- Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009
- (2014) Sung-Yun Pai et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
- (2014) Salima Hacein-Bey-Abina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy for Wiskott-Aldrich Syndrome--Long-Term Efficacy and Genotoxicity
- (2014) C. J. Braun et al. Science Translational Medicine
- SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID
- (2013) C. Schuetz et al. BLOOD
- CD4+ T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer
- (2013) L. Passerini et al. Science Translational Medicine
- SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease
- (2012) C. Rivat et al. BLOOD
- Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
- (2012) F. Candotti et al. BLOOD
- Chronic Granulomatous Disease
- (2012) Steven M. Holland HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene
- (2012) Niek P van Til et al. MOLECULAR THERAPY
- Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
- (2012) Claudio Anasetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
- (2011) K Pike-Overzet et al. LEUKEMIA
- Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction
- (2011) H. B. Gaspar et al. Science Translational Medicine
- Hypomorphic Rag mutations can cause destructive midline granulomatous disease
- (2010) S. S. De Ravin et al. BLOOD
- Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK
- (2010) Y Y Ng et al. LEUKEMIA
- Gene Therapy of Canine Leukocyte Adhesion Deficiency Using Lentiviral Vectors With Human CD11b and CD18 Promoters Driving Canine CD18 Expression
- (2010) Michael J Hunter et al. MOLECULAR THERAPY
- Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome
- (2010) Kaan Boztug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome
- (2009) P. L. Poliani et al. BLOOD
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
- (2009) Alessandro Aiuti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allogeneic Hematopoietic Stem-Cell Transplantation for Leukocyte Adhesion Deficiency
- (2009) W. Qasim et al. PEDIATRICS
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness
- (2008) Chantal Lagresle-Peyrou et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search